The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Multiple Myeloma Channel is supported with funding from Sanofi (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2026 | Preparing community centers for the administration of bispecific antibodies
In this video, Amrita Krishnan, MD, City of Hope, Duarte, CA, briefly comments on practices for preparing community centers for the safe administration of bispecific antibodies. She highlights the feasibility of outpatient administration of these agents and the importance of educating the community about prophylactic measures to reduce the risk of cytokine release syndrome (CRS) and infection. This interview took place during the 2026 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
